LP
PRCT icon

LMR Partners’s Procept Biorobotics PRCT Stock Holding History

LMR Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,427
Closed -$491K – 1593
2025
Q1 		$491K Buy
+8,427
New +$575K ﹤0.01% 919
2024
Q4 		– Sell
-23,361
Closed -$1.87M – 1519
2024
Q3 		$1.87M Buy
23,361
+9,072
+63% +$645K 0.01% 625
2024
Q2 		$873K Buy
+14,289
New +$850K 0.01% 688
2021
Q4 		– Sell
-32,800
Closed -$1.25M – 1249
2021
Q3 		$1.25M Buy
+32,800
New +$1.26M 0.01% 576

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

LMR Partners's PRCT Position: Q2 2025 in Review

LMR Partners sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 8,427 shares — an estimated $491K sold.

LMR Partners first reported a position in PRCT in Q3 2021 and held it in 4 quarters. The position peaked at $1.87M in Q3 2024. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • LMR Partners reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • LMR Partners sold 8,427 Procept Biorobotics shares in Q2 2025, an estimated $491K.
  • LMR Partners first reported a position in Procept Biorobotics in Q3 2021 and held it in 4 quarters.
  • LMR Partners's Procept Biorobotics position peaked at $1.87M in Q3 2024.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.